In use by hospital systems, state agencies, insurance plans, and self-funded employers, HabitNu DPP is an evidenced-based personalized lifestyle change program focused on preventing type 2 diabetes. HabitNu DPP is modeled after CDC’s National Diabetes Prevention Program and can be delivered in-person or online (virtually) in a small group setting under the guidance of a health coach. Lasting one year, HabitNu DPP provides participants with lifestyle modification support around healthy eating, increased physical activity, and stress reduction. The curriculum delivers a “lifestyle modification” approach in which participants receive personal coaching, education, and motivational counseling to help them lose weight by improving their diet and increasing their exercise. HabitNu DPP has received full recognition status by the Centers for Disease Control and Prevention (CDC) to deliver all four modalities of the National Diabetes Prevention Program (in-person, online, distance learning and combination). Learn more at HabitNu.com.

Journeys Metabolic is the first enterprise intervention platform that helps value-based organizations improve clinical and financial outcomes for metabolic disease.

Our HITRUST, EHR-interoperable platform supports population-wide reversal and prevention of metabolic disease via an automated provider workflow engaging qualified targeted patient populations, including those with type 2 diabetes, NAFLD, metabolic syndrome, and obesity. 

The core clinical component is a 4-month, physician developed, digital program that leverages personalized educational content delivery, computer vision for food tracking, and a proprietary metabolic biomarker device. 

Journeys Metabolic is the first enterprise intervention platform that helps value-based organizations improve clinical and financial outcomes for metabolic disease.

Our HITRUST, EHR-interoperable platform supports population-wide reversal and prevention of metabolic disease via an automated provider workflow engaging qualified targeted patient populations, including those with type 2 diabetes, NAFLD, metabolic syndrome, and obesity. The core clinical component is a 4-month, physician developed, digital program that leverages personalized educational content delivery, computer vision for food tracking, and a proprietary metabolic biomarker device. 

The Journeys Metabolic HI-TRUST, EHR-interoperable platform enables clinical and financial decision-makers, including care management teams, to standardize metabolic care for their population health initiatives via an automated provider workflow engaging qualified, targeted patient populations.

Journeys Metabolic is an interoperable, non-prescription behavior modification platform built for VBO's as the first standardized disease reversal and prevention enablement solution in primary care.

Other digital program platforms are non-integrated, disease management point solutions.